As of 2026-03-19, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.11 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-03-16 | -5.67 |
| 2026-03-13 | -5.41 |
| 2026-03-12 | -5.67 |
| 2026-03-11 | -5.67 |
| 2026-03-10 | -6.19 |
| 2026-03-09 | -5.67 |
| 2026-03-06 | -5.67 |
| 2026-03-05 | -5.67 |
| 2026-03-04 | -5.41 |
| 2026-03-03 | -5.16 |
| 2026-03-02 | -4.90 |
| 2026-02-27 | -4.90 |
| 2026-02-26 | -5.41 |
| 2026-02-25 | -5.41 |
| 2026-02-24 | -5.16 |
| 2026-02-23 | -5.16 |
| 2026-02-20 | -5.16 |
| 2026-02-19 | -5.41 |
| 2026-02-18 | -5.41 |
| 2026-02-17 | -5.67 |
| 2026-02-13 | -4.90 |
| 2026-02-12 | -4.90 |
| 2026-02-11 | -4.90 |
| 2026-02-10 | -4.90 |
| 2026-02-09 | -5.16 |
| 2026-02-06 | -5.16 |
| 2026-02-05 | -4.90 |
| 2026-02-04 | -5.16 |
| 2026-02-03 | -5.16 |
| 2026-02-02 | -5.16 |
| 2026-01-30 | -5.16 |
| 2026-01-29 | -5.41 |
| 2026-01-28 | -5.41 |
| 2026-01-27 | -5.16 |
| 2026-01-26 | -5.41 |
| 2026-01-23 | -5.16 |
| 2026-01-22 | -5.41 |
| 2026-01-21 | -5.16 |
| 2026-01-20 | -5.16 |
| 2026-01-19 | -5.41 |
| 2026-01-16 | -5.93 |
| 2026-01-15 | -6.19 |
| 2026-01-14 | -6.19 |
| 2026-01-13 | -5.67 |
| 2026-01-12 | -5.67 |
| 2026-01-09 | -5.67 |
| 2026-01-08 | -6.19 |
| 2026-01-07 | -5.41 |
| 2026-01-06 | -5.16 |
| 2026-01-05 | -5.16 |